Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $505.75 | Total: $2,528.75 |
| 1 | 10 | $428.40 | Total: $4,284.00 |
| 1 | 25 | $362.95 | Total: $9,073.75 |
| 1 | 50 | $309.40 | Total: $15,470.00 |
| 1 | 100 | $267.75 | Total: $26,775.01 |
Overview
(4E)-SUN9221 is a potent dual ?1-adrenergic receptor and 5-HT2 receptor antagonist, exhibiting antihypertensive and antiplatelet aggregation activities in hypertensive rats.
Chemical Properties
| Molecular Formula | C25H31FN4O3 |
| Molecular Weight | 454.54 |
| CAS Numbers | 222318-55-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(CCCN1CCC(C(=O)C2=CC=C(F)C=C2)CC1)N3C4=C(C(=NO)CCN(C)C4=O)C=C3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Mizuno A, et al. Synthesis and pharmacological evaluation of pyrroloazepine derivatives as potent antihypertensive agents with antiplatelet aggregation activity. Chem Pharm Bull [Tokyo]. 1999 Feb;47[2] 246-56.